We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Vacuum-Assisted System Enhances Breast Biopsy Procedures

By HospiMedica International staff writers
Posted on 25 Dec 2012
A next-generation breast biopsy system allows clinicians to collect high quality and larger contiguous tissue samples. More...


The Mammotome Revolve combines the ease of a core needle biopsy with the quality of vacuum assistance, and features an advanced specimen management system capable of collecting and organizing high quality individual tissue samples in numbered, specimen radiograph, and pathology-ready chambers that preserve tissue integrity. Together with proprietary DualVac vacuum technology, physicians can control a variable aperture to confirm or adjust sample acquisition in response to procedural situations, especially when accessing and acquiring challenging lesions. An additional benefit is the efficiency of prebiopsy planning time.

The system is compatible with multiple imaging modalities, enabling breast biopsy to be performed under stereotactic X-ray, ultrasound, magnetic resonance imaging (MRI), or molecular imaging guidance. A full array of tissue markers is available to mark the biopsy site for follow-up observations. The Mammotome revolve vacuum-assisted breast biopsy system is a product of Devicor Medical Products (Cincinnati, OH, USA), and has been approved by the US Food and Drug Administration (FDA).

“Mammotome Revolve uses breakthrough technology that offers peace of mind for clinicians and the patients they treat. With this new product, clinicians can be confident that patients are more likely to have a less painful and traumatic experience,” said Tom Daulton, President and CEO of Devicor. “The success of our recent new product innovations demonstrates why Mammotome is the undisputed worldwide leader in the field of vacuum assisted breast biopsy.”

“Mammotome Revolve takes efficiency to a whole new level while giving beautiful samples. It’s able to easily sample dense breast tissue, and the speed is remarkable,” added Teri-Ann Gizienski, MD, of Magee-Womens Hospital (Cranberry, PA, USA). “I was able to capture three great tissue samples from the same location, which was nearly impossible before. The collection system keeps the samples organized and so easy to manage, even for the specimen radiograph. This is ideal for physicians and facilities who are very busy, but who still want great tissue. It’s a phenomenal system.”

Related Links:

Devicor Medical Products



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.